iMediSync
Company

Last deal

$6.3M
Local Amount - KRW 7.6B

Amount

Series C

Stage

27.01.2022

Date

6

all rounds

$13.2M

Total amount

General

About Company
iMediSync Inc is an AI-driven platform for early detection and treatment of brain health issues.

Industry

Sector :

Subsector :

Keywords :

Also Known As

(주)아이메디신

founded date

18.12.2012

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

iMediSync Inc is an AI-driven platform that focuses on early detection and treatment of brain health issues. Their iSyncBrain platform offers cloud-based artificial intelligence EEG analysis, which has been registered as a class II medical device. They also provide an AI cloud-based solution for heart rate variability analysis called iSyncHeart. Their goal is to develop biomarkers for neurological disorders and provide integrative mental care through EEG analysis and neuromodulation.